| Product Code: ETC8540045 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands saw a significant increase in hemostatic agents import shipments in 2024, with top exporting countries being China, Germany, UK, USA, and Belgium. The market concentration, as measured by HHI, remained at moderate levels, indicating a competitive landscape. The impressive compound annual growth rate (CAGR) of 28.17% from 2020 to 2024 highlights the growing demand for hemostatic agents in the Netherlands. Furthermore, the growth rate of 4.61% from 2023 to 2024 suggests a steady expansion in the market, presenting opportunities for both local and international suppliers to capitalize on this trend.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Hemostatic Agents Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Hemostatic Agents Market - Industry Life Cycle |
3.4 Netherlands Hemostatic Agents Market - Porter's Five Forces |
3.5 Netherlands Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Netherlands Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in the Netherlands |
4.2.2 Growing prevalence of chronic diseases leading to higher demand for hemostatic agents |
4.2.3 Technological advancements in hemostatic products leading to improved efficacy and safety |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of hemostatic agents |
4.3.2 High cost associated with advanced hemostatic agents impacting adoption rates |
5 Netherlands Hemostatic Agents Market Trends |
6 Netherlands Hemostatic Agents Market, By Types |
6.1 Netherlands Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Netherlands Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Netherlands Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Netherlands Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Netherlands Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Netherlands Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Netherlands Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Netherlands Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Netherlands Hemostatic Agents Market Export to Major Countries |
7.2 Netherlands Hemostatic Agents Market Imports from Major Countries |
8 Netherlands Hemostatic Agents Market Key Performance Indicators |
8.1 Average length of hospital stay post-surgery, indicating the effectiveness of hemostatic agents in reducing recovery time |
8.2 Number of new product launches in the hemostatic agents market, reflecting innovation and market growth |
8.3 Adoption rate of minimally invasive surgical procedures, suggesting increased utilization of hemostatic agents |
9 Netherlands Hemostatic Agents Market - Opportunity Assessment |
9.1 Netherlands Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Netherlands Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Hemostatic Agents Market - Competitive Landscape |
10.1 Netherlands Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |